|
US20160000902A1
(en)
*
|
2003-07-11 |
2016-01-07 |
Novavax, Inc. |
Combination vaccine for respiratory syncytial virus and influenza
|
|
DK2347775T3
(da)
|
2005-12-13 |
2020-07-13 |
Harvard College |
Skabeloner til celletransplantation
|
|
WO2009002401A2
(en)
|
2007-06-21 |
2008-12-31 |
President And Fellows Of Harvard College |
Scaffolds for cell collection or elimination
|
|
WO2009079796A1
(en)
|
2007-12-24 |
2009-07-02 |
Id Biomedical Corporation Of Quebec |
Recombinant rsv antigens
|
|
US10328133B2
(en)
|
2008-02-13 |
2019-06-25 |
President And Fellows Of Harvard College |
Continuous cell programming devices
|
|
US9370558B2
(en)
|
2008-02-13 |
2016-06-21 |
President And Fellows Of Harvard College |
Controlled delivery of TLR agonists in structural polymeric devices
|
|
US11446374B2
(en)
|
2008-12-09 |
2022-09-20 |
Novavax, Inc. |
Modified RSV F proteins and methods of their use
|
|
PL3067064T3
(pl)
*
|
2008-12-09 |
2020-11-02 |
Novavax, Inc. |
Zmodyfikowane białka f rsv i sposoby ich wykorzystania
|
|
WO2010149743A2
(en)
|
2009-06-24 |
2010-12-29 |
Id Biomedical Corporation Of Quebec |
Vaccine
|
|
AU2010264688A1
(en)
|
2009-06-24 |
2012-01-19 |
Glaxosmithkline Biologicals S.A. |
Recombinant RSV antigens
|
|
SI3178490T1
(sl)
|
2009-07-15 |
2022-08-31 |
Glaxosmithkline Biologicals S.A. |
Sestavki proteina F RSV-ja in postopki za pripravo le-teh
|
|
CN103977394B
(zh)
*
|
2009-07-17 |
2016-03-09 |
翰林大学校产学协力团 |
包含脂质体包胶的寡核苷酸和表位的免疫刺激性组合物
|
|
WO2011014871A1
(en)
|
2009-07-31 |
2011-02-03 |
President And Fellows Of Harvard College |
Programming of cells for tolerogenic therapies
|
|
US8846056B2
(en)
*
|
2009-08-04 |
2014-09-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control |
Anti-RSV immunogens and methods of immunization
|
|
EP2590675B1
(en)
|
2010-07-07 |
2018-08-29 |
Artificial Cell Technologies, Inc. |
Respiratory syncytial virus antigenic compositions and methods
|
|
CN107648668B
(zh)
|
2010-10-06 |
2021-06-18 |
哈佛学院董事会 |
用于基于材料的细胞疗法的可注射的成孔水凝胶
|
|
US20140024076A1
(en)
*
|
2011-01-28 |
2014-01-23 |
Medimmune, Llc. |
Expression Of Soluble Viral Fusion Glycoproteins In Mammalian Cells
|
|
EA034702B1
(ru)
*
|
2011-04-26 |
2020-03-10 |
Молекулар Экспресс, Инк. |
Липосомные композиции
|
|
WO2012149358A1
(en)
|
2011-04-28 |
2012-11-01 |
President And Fellows Of Harvard College |
Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
|
|
US9675561B2
(en)
|
2011-04-28 |
2017-06-13 |
President And Fellows Of Harvard College |
Injectable cryogel vaccine devices and methods of use thereof
|
|
SI3275892T1
(sl)
|
2011-05-13 |
2020-06-30 |
Glaxosmithkline Biologicals S.A. |
Prefuzijski RSV F antigeni
|
|
AU2012261848B2
(en)
|
2011-06-03 |
2017-06-15 |
President And Fellows Of Harvard College |
In situ antigen-generating cancer vaccine
|
|
ES2395677B1
(es)
*
|
2011-07-29 |
2013-12-26 |
Instituto De Salud Carlos Iii |
Proteína F del VRSH en conformación pre-fusión estabilizada y anticuerpos neutralizantes específicos frente a la misma.
|
|
EP2752199A4
(en)
|
2011-08-29 |
2015-04-29 |
Univ Tokushima |
RSV MUCOSA VACCINE
|
|
CA2849471A1
(en)
*
|
2011-09-30 |
2013-04-04 |
Novavax, Inc. |
Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus
|
|
EP3511337A1
(en)
*
|
2012-04-10 |
2019-07-17 |
The Trustees of The University of Pennsylvania |
Human respiratory syncytial virus concensus antigens, nucleic acid constructs and vaccines made thereform, and methods of using same
|
|
CN104244929B
(zh)
|
2012-04-16 |
2017-04-05 |
哈佛学院董事会 |
用于调节免疫反应的介孔二氧化硅组合物
|
|
DK2879702T3
(da)
*
|
2012-08-01 |
2020-02-24 |
Bavarian Nordic As |
Rekombinant modificeret vacciniavirus ankara (mva)-vaccine mod respiratorisk syncytialvirus (rsv)
|
|
WO2014019718A1
(en)
|
2012-08-01 |
2014-02-06 |
Bavarian Nordic A/S |
Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine
|
|
JP2015525794A
(ja)
*
|
2012-08-06 |
2015-09-07 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
乳児においてｒｓｖ及び百日咳菌に対する免疫応答を惹起するための方法
|
|
US20140037680A1
(en)
*
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
|
BR112015019126A2
(pt)
*
|
2013-02-11 |
2017-08-22 |
Novavax Inc |
Vacina de combinação para vírus sincicial respiratório e influenza
|
|
CA2919773A1
(en)
|
2013-08-05 |
2015-02-12 |
Glaxosmithkline Biologicals S.A. |
Combination immunogenic compositions
|
|
US10682400B2
(en)
|
2014-04-30 |
2020-06-16 |
President And Fellows Of Harvard College |
Combination vaccine devices and methods of killing cancer cells
|
|
CN106659777A
(zh)
|
2014-06-13 |
2017-05-10 |
葛兰素史密丝克莱恩生物有限公司 |
免疫原性组合产品
|
|
EP3250250A4
(en)
|
2015-01-30 |
2019-05-22 |
President and Fellows of Harvard College |
PERITUMORAL AND INTRATUMORAL MATERIALS FOR CANCER THERAPY
|
|
JP7094533B2
(ja)
|
2015-04-10 |
2022-07-04 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
免疫細胞捕捉デバイスおよびその製造および使用方法
|
|
US10426829B2
(en)
|
2015-09-03 |
2019-10-01 |
Novavax, Inc. |
Vaccine compositions having improved stability and immunogenicity
|
|
PE20181354A1
(es)
|
2015-12-23 |
2018-08-22 |
Pfizer |
Mutantes de proteina f de rsv
|
|
EP3411475B1
(en)
|
2016-02-06 |
2025-08-27 |
President and Fellows of Harvard College |
Recapitulating the hematopoietic niche to reconstitute immunity
|
|
CN115537372A
(zh)
|
2016-07-13 |
2022-12-30 |
哈佛学院院长等 |
抗原呈递细胞模拟支架及其制备和使用方法
|
|
EP3493842A4
(en)
|
2016-08-02 |
2020-07-29 |
President and Fellows of Harvard College |
BIOMATERIALS TO MODULATE IMMUNE RESPONSES
|
|
IL264464B2
(en)
|
2016-08-03 |
2024-02-01 |
Lonza Walkersville Inc |
A method for detecting endotoxin using Limulus extract of amoeba, which is mainly free of coagulogen
|
|
GB201620968D0
(en)
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
|
US11352656B2
(en)
*
|
2017-01-11 |
2022-06-07 |
Lonza Walkersville, Inc. |
Coagulogen-free clarified limulus amebocyte lysate and chromogenic assay of endotoxin
|
|
ES3028362T3
(en)
|
2017-07-24 |
2025-06-19 |
Novavax Inc |
Methods and compositions for treating respiratory disease
|
|
WO2019076892A1
(en)
|
2017-10-16 |
2019-04-25 |
Glaxosmithkline Biologicals Sa |
ENHANCED PROMOTER
|
|
US11859199B2
(en)
|
2017-10-16 |
2024-01-02 |
Glaxosmithkline Biologicals Sa |
Adenoviral vectors with two expression cassettes encoding RSV antigenic proteins or fragments thereof
|
|
CN111479926A
(zh)
|
2017-10-16 |
2020-07-31 |
葛兰素史密丝克莱恩生物有限公司 |
具有两个表达盒的猿猴腺病毒载体
|
|
US11905313B2
(en)
|
2017-11-28 |
2024-02-20 |
The United States of America, as represented by the Secretary, Department of Health and Human Services. |
Recombinant RSV G proteins and their use
|
|
CA3092984A1
(en)
|
2018-03-19 |
2019-09-26 |
Novavax, Inc. |
Multivalent influenza nanoparticle vaccines
|
|
CN112638936A
(zh)
|
2018-06-12 |
2021-04-09 |
葛兰素史密丝克莱恩生物有限公司 |
腺病毒多核苷酸和多肽
|
|
WO2020061129A1
(en)
|
2018-09-19 |
2020-03-26 |
President And Fellows Of Harvard College |
Compositions and methods for labeling and modulation of cells in vitro and in vivo
|
|
KR102725189B1
(ko)
|
2018-11-01 |
2024-10-31 |
에스케이바이오사이언스(주) |
재조합 호흡기 세포융합 바이러스 f 단백질 및 이를 포함하는 백신 조성물
|
|
KR102679227B1
(ko)
|
2019-02-28 |
2024-06-28 |
케이엠 바이올로직스 가부시키가이샤 |
Rsv f/g 키메라 백신
|
|
CN114993784B
(zh)
*
|
2022-05-27 |
2025-07-29 |
重庆医科大学 |
一种乙肝病毒颗粒裂解液及其制备与应用
|